Skip to main content
Journal cover image

Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors.

Publication ,  Journal Article
Kwak, S-H; Cochrane, CS; Ennis, AF; Lim, WY; Webster, CG; Cho, J; Fenton, BA; Zhou, P; Hong, J
Published in: Bioorg Chem
September 2020

The UDP-2,3-diacylglucosamine pyrophosphate hydrolase LpxH is essential in lipid A biosynthesis and has emerged as a promising target for the development of novel antibiotics against multidrug-resistant Gram-negative pathogens. Recently, we reported the crystal structure of Klebsiella pneumoniae LpxH in complex with 1 (AZ1), a sulfonyl piperazine LpxH inhibitor. The analysis of the LpxH-AZ1 co-crystal structure and ligand dynamics led to the design of 2 (JH-LPH-28) and 3 (JH-LPH-33) with enhanced LpxH inhibition. In order to harness our recent findings, we prepared and evaluated a series of sulfonyl piperazine analogs with modifications in the phenyl and N-acetyl groups of 3. Herein, we describe the synthesis and structure-activity relationship of sulfonyl piperazine LpxH inhibitors. We also report the structural analysis of an extended N-acyl chain analog 27b (JH-LPH-41) in complex with K. pneumoniae LpxH, revealing that 27b reaches an untapped polar pocket near the di-manganese cluster in the active site of K. pneumoniae LpxH. We expect that our findings will provide designing principles for new LpxH inhibitors and establish important frameworks for the future development of antibiotics against multidrug-resistant Gram-negative pathogens.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Bioorg Chem

DOI

EISSN

1090-2120

Publication Date

September 2020

Volume

102

Start / End Page

104055

Location

United States

Related Subject Headings

  • Structure-Activity Relationship
  • Piperazine
  • Organic Chemistry
  • Humans
  • Enzyme Inhibitors
  • Antinematodal Agents
  • 3405 Organic chemistry
  • 3404 Medicinal and biomolecular chemistry
  • 0305 Organic Chemistry
  • 0304 Medicinal and Biomolecular Chemistry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kwak, S.-H., Cochrane, C. S., Ennis, A. F., Lim, W. Y., Webster, C. G., Cho, J., … Hong, J. (2020). Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors. Bioorg Chem, 102, 104055. https://doi.org/10.1016/j.bioorg.2020.104055
Kwak, Seung-Hwa, C Skyler Cochrane, Amanda F. Ennis, Won Young Lim, Caroline G. Webster, Jae Cho, Benjamin A. Fenton, Pei Zhou, and Jiyong Hong. “Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors.Bioorg Chem 102 (September 2020): 104055. https://doi.org/10.1016/j.bioorg.2020.104055.
Kwak S-H, Cochrane CS, Ennis AF, Lim WY, Webster CG, Cho J, et al. Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors. Bioorg Chem. 2020 Sep;102:104055.
Kwak, Seung-Hwa, et al. “Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors.Bioorg Chem, vol. 102, Sept. 2020, p. 104055. Pubmed, doi:10.1016/j.bioorg.2020.104055.
Kwak S-H, Cochrane CS, Ennis AF, Lim WY, Webster CG, Cho J, Fenton BA, Zhou P, Hong J. Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors. Bioorg Chem. 2020 Sep;102:104055.
Journal cover image

Published In

Bioorg Chem

DOI

EISSN

1090-2120

Publication Date

September 2020

Volume

102

Start / End Page

104055

Location

United States

Related Subject Headings

  • Structure-Activity Relationship
  • Piperazine
  • Organic Chemistry
  • Humans
  • Enzyme Inhibitors
  • Antinematodal Agents
  • 3405 Organic chemistry
  • 3404 Medicinal and biomolecular chemistry
  • 0305 Organic Chemistry
  • 0304 Medicinal and Biomolecular Chemistry